T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,074,006 shares of CABA stock, worth $8.96 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,074,006
Previous 3,673,724
10.9%
Holding current value
$8.96 Million
Previous $17.3 Million
46.67%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$10.5 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$6.31 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.07 Million1.64% of portfolio
-
Jennison Associates LLC2.51MShares$5.53 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $63.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...